Související články - externí
Všechny
- Bevacizumab Approved for Glioblastoma In Japan 18. 6. 2013 Medscape Hematology-Oncology Headlines
- 18th Congress of the European Hematology Association (EHA) 17. 6. 2013 Medscape Hematology-Oncology Headlines
- Second JAK2 Inhibitor for Myelofibrosis Shows Strong Data 17. 6. 2013 Medscape Hematology-Oncology Headlines
- Study Questioning UK Breast Screening Program Is Flawed 14. 6. 2013 Medscape Hematology-Oncology Headlines
- Benefit From CS/HIPEC in Advanced Abdominal Cancers 14. 6. 2013 Medscape Hematology-Oncology Headlines
- ASCO Says 'Time to Raise the Bar' for Clinical Trials 14. 6. 2013 Medscape Hematology-Oncology Headlines
- Significant Off-Label Chemo Use in Elderly Cancer Patients 13. 6. 2013 Medscape Hematology-Oncology Headlines
- Genetic Markers Could Focus Breast Cancer Chemoprevention 13. 6. 2013 Medscape Hematology-Oncology Headlines
- Myriad BRCA Patents Ruled Invalid by US Supreme Court 13. 6. 2013 Medscape Hematology-Oncology Headlines
- Survival Outcomes and Prognostic Factors in Mycosis Fungoides/Sézary Syndrome: Validation of the Revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer Staging Proposal 15. 4. 2011 JCO - hematoonkologické malignity
- Prospective Evaluation of Allogeneic Hematopoietic Stem-Cell Transplantation From Matched Related and Matched Unrelated Donors in Younger Adults With High-Risk Acute Myeloid Leukemia: German-Austrian Trial AMLHD98A 15. 4. 2011 JCO - hematoonkologické malignity
- Improving Relative Survival, But Large Remaining Differences in Survival for Non-Hodgkin's Lymphoma Across Europe and the United States From 1990 to 2004 15. 4. 2011 JCO - hematoonkologické malignity
- Bortezomib Plus Dexamethasone Is Superior to Vincristine Plus Doxorubicin Plus Dexamethasone As Induction Treatment Prior to Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: Results of the IFM 2005-01 Phase III Trial 15. 4. 2011 JCO - hematoonkologické malignity
- Immunohistochemical Methods for Predicting Cell of Origin and Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab 15. 4. 2011 JCO - hematoonkologické malignity
- Light Chain?Induced Acute Renal Failure Can Be Reversed by Bortezomib-Doxorubicin-Dexamethasone in Multiple Myeloma: Results of a Phase II Study 15. 4. 2011 JCO - hematoonkologické malignity
- Bortezomib Plus Dexamethasone Induction Improves Outcome of Patients With t(4;14) Myeloma but Not Outcome of Patients With del(17p) 15. 4. 2011 JCO - hematoonkologické malignity
- Immunohistochemical Methods for Predicting Cell of Origin and Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab 7. 1. 2011 JCO - hematoonkologické malignity
- Improving Relative Survival, But Large Remaining Differences in Survival for Non-Hodgkin's Lymphoma Across Europe and the United States From 1990 to 2004 7. 1. 2011 JCO - hematoonkologické malignity
- ASB2 targets filamins A and B to proteasomal degradation 8. 12. 2008 Blood - hematoonkologické malignity
- Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3 8. 12. 2008 Blood - hematoonkologické malignity
- Inherited and acquired variations in the hyaluronan synthase 1 (HAS1) gene may contribute to disease progression in multiple myeloma and Waldenstrom macroglobulinemia 8. 12. 2008 Blood - hematoonkologické malignity
- Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma 8. 12. 2008 Blood - hematoonkologické malignity
- c-Abl kinase inhibitors overcome CD40-mediated drug resistance in CLL: implications for therapeutic targeting of chemoresistant niches 8. 12. 2008 Blood - hematoonkologické malignity
- Antileukemic effects of the novel, mutant FLT3 inhibitor NVP-AST487: effects on PKC412-sensitive and -resistant FLT3-expressing cells 8. 12. 2008 Blood - hematoonkologické malignity
- Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA 8. 12. 2008 Blood - hematoonkologické malignity
- Etiologic heterogeneity among non-Hodgkin lymphoma subtypes 8. 12. 2008 Blood - hematoonkologické malignity
- Defective synthesis or association of T-cell receptor chains underlies loss of surface T-cell receptor-CD3 expression in enteropathy-associated T-cell lymphoma 8. 12. 2008 Blood - hematoonkologické malignity
Blood - hematoonkologické malignity
- Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3 8. 12. 2008 Blood - hematoonkologické malignity
- Defective synthesis or association of T-cell receptor chains underlies loss of surface T-cell receptor-CD3 expression in enteropathy-associated T-cell lymphoma 8. 12. 2008 Blood - hematoonkologické malignity
- Inherited and acquired variations in the hyaluronan synthase 1 (HAS1) gene may contribute to disease progression in multiple myeloma and Waldenstrom macroglobulinemia 8. 12. 2008 Blood - hematoonkologické malignity
- Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA 8. 12. 2008 Blood - hematoonkologické malignity
- ASB2 targets filamins A and B to proteasomal degradation 8. 12. 2008 Blood - hematoonkologické malignity
- c-Abl kinase inhibitors overcome CD40-mediated drug resistance in CLL: implications for therapeutic targeting of chemoresistant niches 8. 12. 2008 Blood - hematoonkologické malignity
- Etiologic heterogeneity among non-Hodgkin lymphoma subtypes 8. 12. 2008 Blood - hematoonkologické malignity
- Antileukemic effects of the novel, mutant FLT3 inhibitor NVP-AST487: effects on PKC412-sensitive and -resistant FLT3-expressing cells 8. 12. 2008 Blood - hematoonkologické malignity
- Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma 8. 12. 2008 Blood - hematoonkologické malignity
JCO - hematoonkologické malignity
- Improving Relative Survival, But Large Remaining Differences in Survival for Non-Hodgkin's Lymphoma Across Europe and the United States From 1990 to 2004 15. 4. 2011 JCO - hematoonkologické malignity
- Immunohistochemical Methods for Predicting Cell of Origin and Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab 15. 4. 2011 JCO - hematoonkologické malignity
- Survival Outcomes and Prognostic Factors in Mycosis Fungoides/Sézary Syndrome: Validation of the Revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer Staging Proposal 15. 4. 2011 JCO - hematoonkologické malignity
- Bortezomib Plus Dexamethasone Is Superior to Vincristine Plus Doxorubicin Plus Dexamethasone As Induction Treatment Prior to Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: Results of the IFM 2005-01 Phase III Trial 15. 4. 2011 JCO - hematoonkologické malignity
- Bortezomib Plus Dexamethasone Induction Improves Outcome of Patients With t(4;14) Myeloma but Not Outcome of Patients With del(17p) 15. 4. 2011 JCO - hematoonkologické malignity
- Light Chain?Induced Acute Renal Failure Can Be Reversed by Bortezomib-Doxorubicin-Dexamethasone in Multiple Myeloma: Results of a Phase II Study 15. 4. 2011 JCO - hematoonkologické malignity
- Prospective Evaluation of Allogeneic Hematopoietic Stem-Cell Transplantation From Matched Related and Matched Unrelated Donors in Younger Adults With High-Risk Acute Myeloid Leukemia: German-Austrian Trial AMLHD98A 15. 4. 2011 JCO - hematoonkologické malignity
- Improving Relative Survival, But Large Remaining Differences in Survival for Non-Hodgkin's Lymphoma Across Europe and the United States From 1990 to 2004 7. 1. 2011 JCO - hematoonkologické malignity
- Immunohistochemical Methods for Predicting Cell of Origin and Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab 7. 1. 2011 JCO - hematoonkologické malignity
Medscape Hematology-Oncology Headlines
- Bevacizumab Approved for Glioblastoma In Japan 18. 6. 2013 Medscape Hematology-Oncology Headlines
- Second JAK2 Inhibitor for Myelofibrosis Shows Strong Data 17. 6. 2013 Medscape Hematology-Oncology Headlines
- 18th Congress of the European Hematology Association (EHA) 17. 6. 2013 Medscape Hematology-Oncology Headlines
- Study Questioning UK Breast Screening Program Is Flawed 14. 6. 2013 Medscape Hematology-Oncology Headlines
- ASCO Says 'Time to Raise the Bar' for Clinical Trials 14. 6. 2013 Medscape Hematology-Oncology Headlines
- Benefit From CS/HIPEC in Advanced Abdominal Cancers 14. 6. 2013 Medscape Hematology-Oncology Headlines
- Genetic Markers Could Focus Breast Cancer Chemoprevention 13. 6. 2013 Medscape Hematology-Oncology Headlines
- Significant Off-Label Chemo Use in Elderly Cancer Patients 13. 6. 2013 Medscape Hematology-Oncology Headlines
- Myriad BRCA Patents Ruled Invalid by US Supreme Court 13. 6. 2013 Medscape Hematology-Oncology Headlines
V hematoonkologické části sekce Moje vzdělání najdete jednotlivé audiovizuální přednášky (webcasty) i celé zaznamenané semináře natočené s našimi odborníky speciálně pro portál MojeMedicína. Odborné i organizační informace naleznete v odkazech na nejnovější hematoonkologické články publikované v časopisech Blood a Journal of Clinical Oncology. Dále je pro Vás připraven přehled aktualit na portálu Medscape (viz související články). Specifické informace o jednotlivých diagnózách naleznete v sekci Moje praxe. Lékařům jsou k dispozici informace ke specializačnímu studiu hematoonkologie a také návody a rady k přípravě na další stupně vzdělávání.
Z obsahu:
- Therapeutické oblasti: Hemato-Onkologie
